News and Updates

Treatment resistant depression (TRD) is a subcategory of Major Depressive Disorder. There are various definitions but, broadly, it is a type of depression that does not respond to traditional therapies. It is quite common; in fact, a 2022 study found that up to 60 percent of psychiatric patients experience treatment resistance. Despite this number, alternative…

Psilocybin has gained recent media attention for its potential as a therapeutic in the treatment of Major Depressive Disorder. Just this month, a Canadian pharmaceuticals company, Cybin, received approval to conduct Phase II of its psilocybin formulation, named CYB001. What is Psilocybin? Psilocybin is a compound found in some 200 species of fungi. Upon ingestion,…

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders among children.  As of 2016, the CDC estimates that there are 6.1 million children between the ages of two and 17 with ADHD in the United States. While it is more common in children, ADHD is also present in millions of American…

Pain and depression often go hand-in-hand. It may not be surprising, then, to learn that a certain drug could be useful in treating both conditions. Ketamine, for example, has been well-established as a treatment for Major Depressive Disorder. More recently, this drug has been researched as a means of treating certain chronic pain conditions. How…

What Is Chronic Pain? In the medical community, time markers are often used to assist in the diagnosis of chronic pain. Many physicians, for example, consider pain to be “chronic” when it is present for more than 3 months. However, there is some debate as to the usefulness of these markers, as they tend to…